English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Oct 6, 2025

UTHealth Houston launches NIH-funded program for kidney and blood disease research training
+ Pharmaceuticals
Patient Daily | Oct 3, 2025

Oral Health Foundation names Dr Rachael England as head of policy and advocacy
+ Pharmaceuticals
Patient Daily | Oct 3, 2025

Baylor-led study reveals key differences among infectious norovirus strains
+ Pharmaceuticals
Patient Daily | Oct 2, 2025

Texas Medical Center receives NIH grant for kidney, urologic, hematologic research training
+ Pharmaceuticals
Patient Daily | Oct 2, 2025

UTHealth Houston receives $3.1 million grant for cocaine addiction research
+ Pharmaceuticals
Patient Daily | Oct 2, 2025

National health organizations call for passage of SOAR Act on World Oxygen Day
+ Pharmaceuticals
Patient Daily | Oct 1, 2025

Oral health experts agree on new guidance for managing dental plaque biofilm
+ Pharmaceuticals
Patient Daily | Oct 1, 2025

UTHealth Houston researchers receive $2.7 million grant to study semaglutide for cocaine addiction

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes